查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466141

基因检测市场：按产品类型、技术、应用、分销管道、最终用户划分 - 全球预测 2024-2030

Genetic Testing Market by Product (Consumables & Equipment, Software & Services), Test Type (Carrier Testing, Diagnostic Testing, New Born Screening), Technology, Application, Distribution Channel, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年基因检测市场规模为118.9亿美元，预计2024年将达135.5亿美元，2030年将达297.9亿美元，复合年增长率为14.01%。

基因检测包括各种产品和服务，可分析个体的 DNA，以识别与遗传特征、疾病易感性和治疗反应相关的特定基因、染色体和蛋白质。临床诊断、药物研发、生物技术创新、法医学、营养基因体学和直接面向消费者的服务等各个领域都是该市场的重要业务领域。近年来，有几个因素促成了基因检测市场的显着成长。 DNA测序技术（例如次世代定序(NGS)）的进步、人们对透过基因检测进行早期诊断的益处的认识不断提高、遗传性疾病盛行率的增加、人口老龄化以及对个人化医疗的需求增加，消费者基因检测服务的使用不断增加。基因检测市场的新成长机会包括与人工智慧（AI）、巨量资料分析和远端医疗平台等其他最尖端科技的整合，进入亚太地区等高成长市场，以及加强官民合作关係组研究倡议。结果、应用针对个人遗传特征的精准医疗计划，以及使用液态切片技术透过血液样本中的循环肿瘤 DNA (ctDNA) 检测早期癌症。然而，关于滥用遗传资讯的隐私问题和伦理问题、公众对基因检测重要性缺乏认识、由于对某些人群进行高级检测的成本高昂而造成的经济限制，以及增长潜力受到一些限制和挑战的阻碍包括不一致的指导方针和法规、对导致医疗保健专业人员和患者误解的虚假结果的担忧，以及认证遗传咨询师等领域的劳动力短缺。

主要市场统计
基准年[2023] 118.9亿美元
预测年份 [2024] 135.5亿美元
预测年份 [2030] 297.9亿美元
复合年增长率（%） 14.01%

基因检测市场的创新和研发是由CRISPR-Cas9等新型基因编辑技术的发展、生物资讯工具的增强以更好地解释高通量测序平台生成的大量基因组资料以及无细胞基因组数据驱动的。应是探索使用胎儿DNA (cffDNA) 的非侵入性产前检测(NIPT) 的新应用；透过药物基因组学方法发现针对目标疾病状态的独特生物标记；扩展到环境基因组学等领域，以评估个体对各种环境的反应；因素。

产品：高效资料管理和分析的软体和服务的普及

基因检测产业的耗材和设备包括试剂、检测套件、实验室器具以及收集、处理和分析样本所需的设备等产品。此栏位对于在各种应用中执行准确可靠的测试至关重要。诊断实验室需要高品质的耗材，包括试剂和检测试剂套件，以实现准确的疾病诊断。此外，研究机构需要定序仪和PCR装置等先进设备来进行分子层面的基因研究。同时，软体和服务包括用于资料储存、管理和分析的生物资讯学工具，以及遗传咨询和咨询服务。我们的软体和服务专注于资料管理和分析解决方案，以满足高效处理复杂基因组资料日益增长的需求。

测试类型：着重于诊断特定疾病的诊断测试。

基因带原检测是为了识别携带一份基因突变副本的个体的后代，这种基因突变与其他携带者配对时会导致遗传疾病。通常会建议计划生育的夫妇，尤其是有某些遗传性疾病家族病史的夫妇。另一方面，诊断测试是在个体出现疾病症状后或需要确认或排除特定诊断时进行的。新生儿筛检测试有助于儘早发现新生儿潜在危及生命的感染疾病，并立即采取医疗干预措施。此测试通常涉及出生后立即抽血，也可能包括针对先天性心臟疾病的听力测试和脉搏血氧计测试。药物基因体学研究揭示了个体的基因组成如何影响药物反应。了解这些差异可以帮助医疗保健专业人员优化药物治疗选择和剂量，并改善治疗结果。胚胎着床前诊断是对透过体外受精（IVF）获得的胚胎进行，以在胚胎着床前识别先天性异常。胚胎着床前测试主要有两种类型：胚胎着床前基因诊断（PGD），用于筛检特定的遗传疾病；以及胚胎着床前遗传筛检（PGS），用于评估胚胎的染色体组成。产前检测有助于发现怀孕期间潜在的健康问题，包括诊断测试（例如羊膜穿刺术）和筛检测试（例如非侵入性产前测试（NIPT））。无症状性和预测测试可识别无症状性人群的基因突变，这些人在以后的生活中患某种特定疾病的风险可能更高。这些检测资讯使个人能够就医疗保健策略做出明智的决定，并采取预防措施来降低疾病风险。

技术：更多地转向 DNA序列测定，以实现准确的基因识别和疾病诊断

细胞遗传学是对染色体异常及其在遗传性疾病中的作用的研究。细胞遗传学技术分析染色体的结构和数量，以识别可能与疾病发展有关的异常。常见的细胞遗传学测试包括核型分析和萤光原位杂合反应（FISH）。 DNA序列测定技术可破解 DNA 分子内核苷酸的​​确切顺序，识别基因并确定其功能。这项技术对于诊断遗传疾病、检测癌细胞内的基因突变以及指南个人化医疗方法有着很高的需求。基因表现同时测量数千个基因的活性水平，以了解基因在疾病发生和进展中的作用。基因表现技术可用于识别新的治疗标靶、了解治疗反应和指南个人化治疗决策。微阵列和 RNA 定序 (RNA-seq) 是基因表现谱分析的常用技术。微阵列是用于分析基因表现和检测单核苷酸多态性 (SNP) 等遗传变异的高通量技术平台。选择取决于您的需求，例如在基因组层面上研究基因功能或筛检潜在的疾病相关生物标记。 PCR 是一种广泛使用的分子生物学方法，用于扩增和定量特定 DNA 序列。 PCR 有多种应用，包括基因检测、病原体检测和法医学分析。 PCR 的需求量很大，因为它可以用最少的样品提供快速、准确的结果。

应用 越来越多地采用基因检测来检测癌症的早期迹象

自体免疫疾病是由免疫系统功能失调引起的，免疫系统会攻击身体的细胞和组织。基因检测对于确定这些疾病的遗传倾向并实现早期检测和有针对性的治疗计划至关重要。全面了解个人的遗传倾向有助于检测癌症的早期迹象并识别遗传性风险，从而製定个人化的预防策略和标靶治疗。心臟病、糖尿病和肥胖是环境因素和遗传因素的复杂组合。基因检测可以帮助确定个人对这些疾病的易感性，并制定量身定制的生活方式干预措施和药物治疗方案以降低风险。囊肿纤维化、肌肉萎缩症和地中海贫血是由特定基因突变引起的。基因检测可以准确诊断遗传疾病，并且可以透过携带者筛检来识别计划生育的高风险夫妻。阿兹海默症、帕金森氏症和亨廷顿舞蹈症等神经退化性疾病可能与遗传密切相关。基因检测可以揭示这些疾病的易感性，并采取预防措施和早期疗育来减缓疾病的进展。

销售管道：基因检测产品线上平台投放

线下分发包括医院、诊所和诊断实验室等传统实体场所，针对寻求医疗保健专业人员面对面个性化指导的个人。线下销售的主要好处包括与医疗专业人员的直接咨询、安全的样本采集通讯协定、全面的保险范围选项以及在需要时即时获得后续护理。线上销售是基因检测市场中快速增长的部分，吸引了那些寻求在家中方便访问的精通技术的个人。主要的直接面向消费者 (DTC) 品牌主要透过其网站和电子商务平台提供谱系和健康相关测试。线上基因检测的优点包括易于使用（样本采集套件直接邮寄给使用者）、週转时间短、成本效益高以及可以进行广泛的检测。然而，透过线下管道提供的个人化医疗支援可能缺乏。最终，线下和线上分销的选择将取决于个人偏好和需求。

最终使用者：基因检测解决方案广泛应用于医院和诊所的疾病诊断和治疗计划。

在基因检测中，诊断实验室的专业服务和广泛的检测项目发挥着重要作用。由于对直接面向消费者 (DTC) 测试的需求不断增长，家庭基因测试越来越受欢迎，这种测试可以深入了解血统、健康风险和个人特征。医院和诊所是最终用户的另一个重要组成部分，因为它们将基因检测服务整合到疾病诊断和治疗计划的患者护理途径中。医院开始结合药物基因体学学测试，根据患者的遗传倾向定製药物选择。

区域洞察

美洲先进的医疗基础设施和政府对研发的大力支持导致了基因检测市场的蓬勃发展。然而，监管挑战仍然存在，因为製造商必须遵守食品药物管理局(FDA) 等机构制定的严格准则。欧洲的情况多种多样，各成员国的法规也有所不同。英国脱欧为英国的法律规范带来了不确定性。製造商和供应商必须根据每个国家的具体要求制定策略。由于人口不断增长和慢性病患病率不断上升，中东和非洲对于医疗保健提供者俱有巨大潜力。然而，由于医疗基础设施有限和基因检测服务意识较低，进入这些市场面临挑战。亚太地区在中国、日本和印度提供了巨大的成长机会，这些地区的大量患者需要对遗传疾病进行准确的诊断和积极的管理。儘管存在与已开发国家类似的监管障碍，但仍有创新空间来满足当地需求。基因检测正在成为已开发国家个人化医疗和预防性医疗保健不可或缺的一部分，但应对复杂的法规至关重要。在新兴国家，由于市场扩张的潜力，我们正在投资当地合作伙伴关係、教育计画和基础设施发展。最近的新闻凸显了旨在改善基因检测市场产品供应的合作。透过跟上区域趋势并相应调整策略，全球基因检测趋势最终将为全球公共卫生成果做出重大贡献。

FPNV定位矩阵

FPNV定位矩阵对于评估基因检测市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对基因检测市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.基因检测市场规模及预测如何？

2.基因检测市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3.基因检测市场的技术趋势和法规结构是什么？

4.基因检测市场主要厂商的市场占有率为何？

5.进入基因检测市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 遗传性疾病和肿瘤疾病的盛行率以及精准医疗的需求
      • 政府的基因检测措施和自我检测套组的普及
    • 抑制因素
      • 对基因检测中假阳性和假阴性的担忧
    • 机会
      • 基因检测技术的持续研究与新进展
      • 透过远端医疗和数位健康平台进行基因检测的出现
    • 任务
      • 基因检测的后勤障碍与隐私问题
  • 市场区隔分析
    • 产品：高效资料管理和分析的软体和服务的普及
    • 测试类型：着重于诊断特定疾病的诊断测试
    • 技术：更多地转向 DNA定序，以实现准确的基因识别和疾病诊断
    • 应用：更多地采用基因检测来检测癌症的早期征兆
    • 分销管道：基因检测产品投放至线上平台
    • 最终使用者：基因检测解决方案广泛应用于医院和诊所的疾病诊断和治疗计划。
  • 市场趋势分析
    • 技术进步和成熟製药公司的存在正在推动美洲基因检测市场的成长。
    • 慢性病的增加和医疗基础设施的扩张将支持亚太地区的基因检测。
    • 政府措施和对个人化医疗日益增长的需求正在推动欧洲、中东和非洲地区基因检测市场的成长。
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析

第六章 基因检测市场：副产品

  • 耗材及设备
  • 软体和服务

第七章按测试类型分類的基因测试市场

  • 职业测试
  • 诊断测试
  • 新生儿筛检
  • 药物基因组学
  • 胚胎着床前测试
  • 产前检测
  • 症状前和预测测试

第八章 基因检测市场：依技术分类

  • 细胞遗传学
  • DNA序列分析
  • 基因表现
  • 微阵列
  • PCR

第九章 基因检测市场：依应用分类

  • 自体免疫疾病
  • 癌症
  • 慢性疾病
  • 遗传疾病
  • 神经退化性疾病

第10章基因检测市场：依分销管道划分

  • 离线
  • 在线的

第十一章 基因检测市场：依最终用户分类

  • 诊断实验室
  • 主页设定
  • 医院/诊所

第十二章 美洲基因检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太基因检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章 欧洲、中东、非洲基因检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • DNA 公司 Asa Ren 融资 800 万美元，更多细节公布
    • Devyser 宣布两种针对遗传性癌症的新基因检测解决方案
    • Blueprint Genetics 推出了一系列新的筛检测试，为计划生育和未来健康提供可行的见解。
    • Kindbody推出Kindlabs，引进内部基因检测
    • 基因检测 Delve 获得 3500 万美元创业投资资金
    • FBI核准QIAGEN 基于 NGS 的 ForenSeq MainstAY 工作流程用于美国国家 DNA 索引系统 (NDIS)
    • Sema4将以6.23亿美元收购基因检测公司GeneDx
    • Scribe 与赛诺菲扩大基因疗法开发协议
    • healthOme 收购 Kailos Genetics
    • MapMyGenome 推出印度首个个人化护肤和头髮护理 DNA 测试
    • CENTOGENE 扩大与武田的策略伙伴关係，持续为溶小体贮积症患者提供基因检测服务
    • PathogenDx 扩大了取得专利的多重分子检测技术的范围，并将其引入临床、食品和农业领域。
    • 安捷伦宣布收​​购用于癌症研究的高性能 NGS靶向序列捕获工作流程开发商 Avida Biomed
    • Invitae 宣布与 Epic 合作简化基因检测
    • 综合DNA检测DNATEST.ID在印尼隆重推出
    • MyHeritage 发布 cMExplainer 以更准确地预测 DNA 匹配之间的家庭关係

第16章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-437E9896A512

[183 Pages Report] The Genetic Testing Market size was estimated at USD 11.89 billion in 2023 and expected to reach USD 13.55 billion in 2024, at a CAGR 14.01% to reach USD 29.79 billion by 2030.

Genetic testing comprises a diverse range of products and services to analyze an individual's DNA to identify specific genes, chromosomes, or proteins linked to inherited traits, disease predispositions, or therapeutic responses. Various sectors, including clinical diagnostics, pharmaceutical research and development, biotechnology innovation, forensics, nutrigenomics, and direct-to-consumer services, are important business sectors in this market. Several factors have contributed to the significant growth of the genetic testing market in recent years. These include advancements in DNA sequencing technologies such as next-generation sequencing (NGS), increased awareness about early diagnosis benefits through genetic testing, growing prevalence of genetic disorders, an aging population, rising demand for personalized medicine, expanding use of direct-to-consumer genetic testing services, and supportive government policies coupled with favorable reimbursement scenarios. Emerging opportunities within the genetic testing market involve integrating with other cutting-edge technologies such as artificial intelligence (AI), big data analytics, and telemedicine platforms; entering high-growth markets such as Asia-Pacific; fostering public-private partnerships to bolster genomic research initiatives; applying precision medicine programs tailored to individual genetic profiles; and using liquid biopsy technology for early cancer detection via circulating tumor DNA (ctDNA) in blood samples. Nevertheless, the growth potential is hampered by several limitations and challenges that include ethical concerns regarding privacy issues and misuse of genetic information; insufficient public awareness about genetic testing's significance; affordability constraints due to high costs of advanced tests for certain segments of the population; inconsistent guidelines and regulations across countries; concerns over false results leading to misinterpretation by healthcare professionals and patients alike; and workforce shortage in areas such as certified genetic counselors.

KEY MARKET STATISTICS
Base Year [2023] USD 11.89 billion
Estimated Year [2024] USD 13.55 billion
Forecast Year [2030] USD 29.79 billion
CAGR (%) 14.01%

Innovation and research efforts in the genetic testing market should be geared towards developing novel gene-editing technologies such as CRISPR-Cas9 for precision editing capabilities, enhancing bioinformatics tools for better interpretation of vast genomic data generated by high-throughput sequencing platforms, exploring new applications in non-invasive prenatal testing (NIPT) using cell-free fetal DNA (cffDNA); discovering unique biomarkers for disease conditions that can be targeted through pharmacogenomics approaches; and expanding into fields such as environmental genomics to assess individual responses to various environmental factors.

Product: Penetration of software and services for efficient data management and analysis

Consumables and equipment in the genetic testing industry include products including reagents, assay kits, lab instruments, and devices required for sample collection, processing, and analysis. This segment is indispensable for performing accurate and reliable tests across various applications. Diagnostic Laboratories require high-quality consumables including reagents and assay kits for accurate diagnosis of diseases. In addition, research institutes rely on advanced equipment including sequencers or PCR machines to study genetics at a molecular level. On the other hand, the software and services includes bioinformatics tools for data storage, management, and analysis, as well as genetic counseling and consulting services. Software and services emphasizes data management and analysis solutions that cater to the growing need for efficient handling of complex genomic data.

Test Type: Emphasis on diagnostic testing to perform particular disease dignosis

Carrier testing is conducted to identify individuals with one copy of a gene mutation responsible for a genetic disorder in their offspring when paired with another carrier. It is often recommended for couples planning to have children, especially when there is a family history of specific genetic conditions. On the other hand, diagnostic testing is performed after an individual develops disease symptoms or needs to confirm or rule out a particular diagnosis. Newborn screening tests help identify potentially life-threatening infections in newborns as early as possible to initiate prompt medical intervention. The tests usually involve blood samples taken shortly after birth and may also include hearing screenings and pulse oximetry tests for congenital heart defects. Pharmacogenomics studies show how an individual's genetic makeup affects their medication response. By understanding these differences, healthcare professionals can optimize drug therapy selection and dosing for improved treatment outcomes. Preimplantation genetic testing is performed on embryos created through in vitro fertilization (IVF) to identify congenital abnormalities before uterine implantation. The two primary types of preimplantation testing are preimplantation genetic diagnosis (PGD), which screens for specific genetic disorders, and preimplantation genetic screening (PGS), which assesses embryo chromosomal makeup. Prenatal testing helps detect potential health problems during pregnancy and includes diagnostic tests (e.g., amniocentesis) and screenings (e.g., non-invasive prenatal testing or NIPT). Presymptomatic and predictive testing identifies genetic mutations in asymptomatic individuals who may be at high risk for developing specific diseases later in life. This testing information allows individuals to make informed decisions about their health management strategies or take preventive measures to reduce disease risk.

Technology: Increasing shift toward DNA sequencing for precise gene identification and disease diagnosis

Cytogenetics is the study of chromosomal abnormalities and their role in genetic disorders. Cytogenetics technology involves analyzing the structure and number of chromosomes and identifying aberrations that may contribute to disease development. Common cytogenetic tests include karyotyping and fluorescence in situ hybridization (FISH). DNA sequencing technology decodes the precise order of nucleotides within DNA molecules to identify genes and determine their function. The need-based preference for this technology lies in its ability to diagnose hereditary conditions, detect genetic mutations in cancer cells, and guide personalized medicine approaches. Gene expression profiling measures the activity levels of thousands of genes simultaneously to understand their role in disease development or progression. Gene expression profiling technology is useful for identifying novel therapeutic targets, understanding treatment responses, and guiding personalized therapy decisions. Microarrays and RNA sequencing (RNA-seq) are commonly used techniques for gene expression profiling. Microarrays are high-throughput technology platforms that analyze gene expression or detect genetic variations such as single nucleotide polymorphisms (SNPs). Their need-based preference includes studying gene function at the genome level or screening for potential disease-related biomarkers. PCR is a widely utilized molecular biology technique for amplifying and quantifying specific DNA sequences. PCR has various applications, including genetic testing, pathogen detection, and forensic analysis. The need-based preference for PCR is its ability to generate results quickly and accurately with minimal sample material.

Application: Rising adoption of genetic testing to detect early signs of cancer

Autoimmune disorders result from an immune system dysfunction, leading it to attack the body's cells and tissues. Genetic testing is crucial in identifying genetic predispositions for these conditions, enabling early detection and targeted treatment plans. A comprehensive understanding of an individual's genetic makeup can help detect early signs of cancer or identify familial risks, allowing for personalized prevention strategies and targeted therapies. Heart disease, diabetes, and obesity have complex interplays between environmental factors and genetics. Genetic testing assists in determining an individual's susceptibility to these conditions and helps develop tailored lifestyle interventions or medication plans to reduce risks. Cystic fibrosis, muscular dystrophy, and thalassemia are caused by mutations in specific genes. Genetic testing enables accurate diagnosis of genetic disorders and allows carrier screening to identify at-risk couples planning to have children. Neurodegenerative diseases, including Alzheimer's, Parkinson's, and Huntington's, can have strong genetic links. Genetic testing helps uncover predispositions to these conditions, enabling preventive measures or early interventions to slow disease progression.

Distribution Channel: Deployment of genetic testing products on online platforms

Offline distribution includes traditional brick-and-mortar establishments such as hospitals, clinics, and diagnostic laboratories, catering to individuals seeking personalized guidance through face-to-face interactions with healthcare professionals. The main benefits of offline distribution are direct consultation with medical experts, secure sample collection protocols, comprehensive insurance coverage options, and immediate access to follow-up care if needed. Online distribution represents a rapidly growing segment in the genetic testing market that appeals to tech-savvy individuals seeking convenient access to services from home. Major direct-to-consumer (DTC) brands predominantly offer ancestry or health-related tests through websites or eCommerce platforms. Advantages of online genetic testing include ease of use (sample collection kits mailed directly to users), quick turnaround times, cost-effectiveness, and access to a wide range of tests. However, it may lack personalized medical support available through offline channels. Ultimately, the choice between offline and online distribution depends on individual preferences and needs.

End-User: Extensive use of genetic testing solutions in hospitals & clinics for disease diagnosis and treatment planning

Diagnostic laboratories play a pivotal role in genetic testing due to their specialized services and extensive range of tests. Home-setting genetic testing is gaining popularity owing to the growing demand for direct-to-consumer (DTC) tests that provide insights into ancestry, health risks, and personal traits. Hospitals and clinics form another essential part of the end-user landscape as they integrate genetic testing services into patient care pathways for disease diagnosis and treatment planning. Hospitals have started incorporating pharmacogenomic testing to help tailor medication selection based on the patient's genetic makeup.

Regional Insights

The advanced healthcare infrastructure and strong government support for research and development in the Americas have led to a thriving genetic testing market. However, regulatory challenges remain as manufacturers must adhere to strict guidelines set by agencies such as the Food Drug Administration (FDA). Europe presents a diverse landscape with varying regulations across its member countries. The UK's Brexit has caused uncertainty in its regulatory framework. Manufacturers or providers must tailor their strategies to each country's specific requirements. The Middle East & Africa have potential for genetic testing providers due to growing populations and the increasing prevalence of chronic diseases. However, limited healthcare infrastructure and a lack of awareness about genetic testing services create challenges for entry into these markets. The APAC region offers major growth opportunities within China, Japan, and India as their large patient populations require accurate diagnosis and proactive management of hereditary conditions. Despite regulatory hurdles similar to those in developed countries, there is room for innovation catering to local context needs. Genetic testing is becoming vital to personalized medicine and preventive healthcare in developed countries; however, navigating complex regulations is crucial. In emerging countries, where potential lies for market expansion investment in local partnerships, educational initiatives, and infrastructure development. Recent news highlights collaborations aimed at improving offerings within the genetic testing market. Global genetic testing offers numerous opportunities to stay informed about regional trends and adapt strategies accordingly, ultimately contributing meaningfully to public health outcomes worldwide.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Genetic Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Genetic Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Genetic Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Blueprint Genetics Oy, Centogene N.V., Color Health, Inc., CooperSurgical Inc., Editas Medicine, Inc., ELITechGroup SAS, Eugene Labs Pty Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Fulgent Genetics, Inc., Gene by Gene, Ltd., GeneDx, LLC, Illumina, Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Living DNA Ltd., Macrogen, Inc., MyHeritage Ltd., Myriad Genetics, Inc., Natera, Inc., Newtopia Inc., PathogenDx Corporation, PerkinElmer Inc., Qiagen N.V., Sanofi S.A., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Genetic Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables & Equipment
    • Software & Services
  • Test Type
    • Carrier Testing
    • Diagnostic Testing
    • New Born Screening
    • Pharmacogenomics
    • Preimplantation Testing
    • Prenatal Testing
    • Presymptomatic & Predictive Testing
  • Technology
    • Cytogenetics
    • DNA Sequencing
    • Gene Expression Profiling
    • Microarrays
    • PCR
  • Application
    • Autoimmune Disorders
    • Cancer
    • Chronic Diseases
    • Genetic Disorders
    • Neurodegenerative Diseases
  • Distribution Channel
    • Offline
    • Online
  • End-User
    • Diagnostic Laboratories
    • Home Setting
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Genetic Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Genetic Testing Market?

3. What are the technology trends and regulatory frameworks in the Genetic Testing Market?

4. What is the market share of the leading vendors in the Genetic Testing Market?

5. Which modes and strategic moves are suitable for entering the Genetic Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of genetic and oncology disorders and need for precision medicine
      • 5.1.1.2. Government initiatives for genetic testing and rise of self-test kits
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with false positives & negatives of genetic tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and new developments in genetic testing technologies
      • 5.1.3.2. Emergence of genetic testing with telehealth and digital health platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Logistical barriers and privacy concerns to genetic testing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Penetration of software and services for efficient data management and analysis
    • 5.2.2. Test Type: Emphasis on diagnostic testing to perform particular disease dignosis
    • 5.2.3. Technology: Increasing shift toward DNA sequencing for precise gene identification and disease diagnosis
    • 5.2.4. Application: Rising adoption of genetic testing to detect early signs of cancer
    • 5.2.5. Distribution Channel: Deployment of genetic testing products on online platforms
    • 5.2.6. End-User: Extensive use of genetic testing solutions in hospitals & clinics for disease diagnosis and treatment planning
  • 5.3. Market Trend Analysis
    • 5.3.1. Technological advances and presence of established pharmaceutical companies enhance the genetic testing market growth in the Americas
    • 5.3.2. Increasing chronic disorders and expanding healthcare infrastructure supports genetic testing in the APAC region.
    • 5.3.3. Government initiatives and increasing demand for personalized medicine expand genetic testing market growth in the EMEA region.
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis

6. Genetic Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables & Equipment
  • 6.3. Software & Services

7. Genetic Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Carrier Testing
  • 7.3. Diagnostic Testing
  • 7.4. New Born Screening
  • 7.5. Pharmacogenomics
  • 7.6. Preimplantation Testing
  • 7.7. Prenatal Testing
  • 7.8. Presymptomatic & Predictive Testing

8. Genetic Testing Market, by Technology

  • 8.1. Introduction
  • 8.2. Cytogenetics
  • 8.3. DNA Sequencing
  • 8.4. Gene Expression Profiling
  • 8.5. Microarrays
  • 8.6. PCR

9. Genetic Testing Market, by Application

  • 9.1. Introduction
  • 9.2. Autoimmune Disorders
  • 9.3. Cancer
  • 9.4. Chronic Diseases
  • 9.5. Genetic Disorders
  • 9.6. Neurodegenerative Diseases

10. Genetic Testing Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Offline
  • 10.3. Online

11. Genetic Testing Market, by End-User

  • 11.1. Introduction
  • 11.2. Diagnostic Laboratories
  • 11.3. Home Setting
  • 11.4. Hospitals & Clinics

12. Americas Genetic Testing Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Genetic Testing Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Genetic Testing Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. DNA company Asa Ren raises USD 8M and more briefs
    • 15.3.2. Devyser launches two new genetic testing solutions for hereditary cancer
    • 15.3.3. Blueprint Genetics introduces the new Screening Tests family; giving actionable insights for family planning, and future health
    • 15.3.4. Kindbody Brings Genetic Testing In-House with the Launch of Kindlabs
    • 15.3.5. Genetic Testing Firm Delve Gets USD 35 Million in VC Funding
    • 15.3.6. FBI approves QIAGEN's NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS)
    • 15.3.7. Sema4 to acquire genetic testing firm GeneDx for USD 623 Million
    • 15.3.8. Scribe and Sanofi expand genetic therapy development deal
    • 15.3.9. healthOme Acquires Kailos Genetics
    • 15.3.10. MapMyGenome launches India's First DNA Test For Personalized Skin And Hair Care
    • 15.3.11. CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
    • 15.3.12. PathogenDx Expands Reach of Its Patented Multiplexed Molecular Testing Technology, Bringing It to the Clinical, Food and Agriculture Sectors
    • 15.3.13. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
    • 15.3.14. Invitae Announces Partnership with Epic to Streamline Genetic Testing
    • 15.3.15. Grand Launching Of DNATEST.ID, A Comprehensive Dna Test In Indonesia
    • 15.3.16. MyHeritage Releases cM Explainer to Predict Familial Relationships Between DNA Matches with Greater Accuracy

16. Competitive Portfolio

  • 16.1. Key Company Profiles
  • 16.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. GENETIC TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. GENETIC TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GENETIC TESTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 18. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 22. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 27. GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 28. GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENETIC TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENETIC TESTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL GENETIC TESTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY CONSUMABLES & EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY CONSUMABLES & EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC & PREDICTIVE TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC & PREDICTIVE TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL GENETIC TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL GENETIC TESTING MARKET SIZE, BY PCR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL GENETIC TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL GENETIC TESTING MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL GENETIC TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL GENETIC TESTING MARKET SIZE, BY ONLINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL GENETIC TESTING MARKET SIZE, BY HOME SETTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL GENETIC TESTING MARKET SIZE, BY HOME SETTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL GENETIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL GENETIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. ARGENTINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 90. ARGENTINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 91. ARGENTINA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. ARGENTINA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 99. BRAZIL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. BRAZIL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. BRAZIL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 102. BRAZIL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 103. BRAZIL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 104. BRAZIL GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 111. CANADA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. CANADA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. CANADA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 114. CANADA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 115. CANADA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 116. CANADA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 123. MEXICO GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. MEXICO GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. MEXICO GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 126. MEXICO GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 127. MEXICO GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 128. MEXICO GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 135. UNITED STATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. UNITED STATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. UNITED STATES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 138. UNITED STATES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 139. UNITED STATES GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. UNITED STATES GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 142. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 162. AUSTRALIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. AUSTRALIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. AUSTRALIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 166. AUSTRALIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 167. AUSTRALIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 168. AUSTRALIA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 171. CHINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. CHINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. CHINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 174. CHINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 175. CHINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. CHINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. CHINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 178. CHINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 179. CHINA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. CHINA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 183. INDIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. INDIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. INDIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 186. INDIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 187. INDIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. INDIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. INDIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 190. INDIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 191. INDIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. INDIA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. INDONESIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. INDONESIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. INDONESIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 198. INDONESIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 199. INDONESIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. INDONESIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. INDONESIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 202. INDONESIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 203. INDONESIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. INDONESIA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 207. JAPAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. JAPAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. JAPAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 210. JAPAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 211. JAPAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. JAPAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. JAPAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 214. JAPAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 215. JAPAN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. JAPAN GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. MALAYSIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. MALAYSIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. MALAYSIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 222. MALAYSIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 223. MALAYSIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. MALAYSIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. MALAYSIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 226. MALAYSIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 227. MALAYSIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. MALAYSIA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. PHILIPPINES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 234. PHILIPPINES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 235. PHILIPPINES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. PHILIPPINES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. PHILIPPINES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 238. PHILIPPINES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 239. PHILIPPINES GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. PHILIPPINES GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 243. SINGAPORE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. SINGAPORE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. SINGAPORE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 246. SINGAPORE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 247. SINGAPORE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. SINGAPORE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SINGAPORE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 250. SINGAPORE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 251. SINGAPORE GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. SINGAPORE GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 259. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 262. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 263. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 264. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 267. TAIWAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. TAIWAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. TAIWAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 270. TAIWAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 271. TAIWAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. TAIWAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. TAIWAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 274. TAIWAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 275. TAIWAN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. TAIWAN GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. THAILAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. THAILAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. THAILAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 282. THAILAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 283. THAILAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. THAILAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. THAILAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 286. THAILAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 287. THAILAND GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 288. THAILAND GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 290. VIETNAM GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 291. VIETNAM GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. VIETNAM GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. VIETNAM GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 294. VIETNAM GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 295. VIETNAM GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 296. VIETNAM GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 297. VIETNAM GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 298. VIETNAM GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 299. VIETNAM GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 300. VIETNAM GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 313. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 314. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 315. DENMARK GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 316. DENMARK GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 317. DENMARK GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 318. DENMARK GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 319. DENMARK GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 320. DENMARK GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 321. DENMARK GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 322. DENMARK GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 323. DENMARK GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 324. DENMARK GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 325. DENMARK GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 326. DENMARK GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 327. EGYPT GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 328. EGYPT GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 329. EGYPT GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 330. EGYPT GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 331. EGYPT GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 332. EGYPT GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 333. EGYPT GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 334. EGYPT GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 335. EGYPT GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 336. EGYPT GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 337. EGYPT GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 338. EGYPT GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 339. FINLAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 340. FINLAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 341. FINLAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 342. FINLAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 343. FINLAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 344. FINLAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 345. FINLAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 346. FINLAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 347. FINLAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 348. FINLAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 349. FINLAND GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 350. FINLAND GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 351. FRANCE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 352. FRANCE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 353. FRANCE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 354. FRANCE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 355. FRANCE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 356. FRANCE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 357. FRANCE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 358. FRANCE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 359. FRANCE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 360. FRANCE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 361. FRANCE GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 362. FRANCE GENETIC TESTIN